NCT07455656

Brief Summary

To study the effect vitamin D effect on orthodontic tooth movement when used in combination with coticision technique, independent t test or an equivalent non-parametric test will be used for comparison. According to a previous study by (S. T. Varughese, et al. (2019) , "Effect of vitamin D on canine distalization and alveolar bone density using multi-slice spiral CT: a randomized controlled trial

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
13mo left

Started Aug 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Aug 2025Aug 2027

Study Start

First participant enrolled

August 1, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 15, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

March 6, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2027

Last Updated

March 6, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

November 15, 2025

Last Update Submit

March 3, 2026

Conditions

Keywords

Orhodontic tooth movementCanine retractionExtraction first premolars

Outcome Measures

Primary Outcomes (1)

  • Rate of canine retraction

    The linear distance of canine movement (in millimeters) was measured from a fixed reference point on dental casts or digital models at baseline and monthly intervals to determine the acceleration effect of local vitamin D3 administration and cortisone.

    baseline to 3 months after initiation of canine retraction

Secondary Outcomes (1)

  • evaluate the changes in the alveolar bone density

    baseline to 3 months after initiation of canine retraction

Study Arms (2)

patients will receive local application of vitamin D3 combined with corticision

EXPERIMENTAL

patients will receive local application of vitamin D3 combined with corticision

Drug: patients will receive local application of vitamin D3 combined with corticision

Control

NO INTERVENTION

patients will receive conventional treatment

Interventions

Administration of the Solution at eexperimental side: One milliliter of was injected into the buccal vestibule at the level of the distal margin of the root of the canine. One milliliter of (ONE ALPHA 2 MCG / ML 10 AMP 0.5 ML Leo Pharmaceutical products Ballerup - Denmark. Imported by: Egyptian Company for Drug Trading) was injected four times during treatment on the the beginning (T0), 4 weeks (T1), 8 weeks (T2), and 12 weeks (T3) of canine retraction on both sides according to Varughese, et al. " Participants were evaluated from the beginning (T0), 4 weeks (T1), 8 weeks (T2), and 12 weeks (T3) of canine distalization. At these appointments, impressions were made to obtain the study models. Multi-slice spiral computed tomography scans were taken at T0 and T3 to measure the changes in bone density following canine distalization. The primary outcome was to evaluate the rate and total amount of canine distalization as well as anchorage loss in the maxillary arch. All study measurements

patients will receive local application of vitamin D3 combined with corticision

Eligibility Criteria

Age13 Years - 20 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Orthodontic patients referred for therapeutic extraction of bilateral maxillary first premolars (Angle Class II division 1 cases, with crowding and bimaxillary protrusion).
  • Fully erupted permanent teeth (except third molar).
  • Age 13-20 patients.
  • No previous orthodontic treatment.
  • Good oral and general health.
  • No systemic disease or regular medication that could interfere with and/or affect orthodontic teeth movement.

You may not qualify if:

  • Patients with impacted canines.
  • Patients with severe crowding.
  • Patients with untreated decay or any endodontic lesions.
  • Patients with thyroid, parathyroid, or renal and liver disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Orthodontic Outpatient Clinic, Faculty of Dental Medicine, Al-Azhar University

Cairo, Cairo Governorate, 11651, Egypt

RECRUITING

MeSH Terms

Conditions

Malocclusion

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic Diseases

Study Officials

  • Dr. Ramadan Yusuf Abu-Shahba Y Dr. Ramadan Yusuf Abu-Shahba, PhD

    rmadanyusf@azhar.edu.eg

    STUDY DIRECTOR

Central Study Contacts

Mahmoud Elsaid Elsayed E Mahmoud Elsaid, BDS

CONTACT

Dr. Mahmoud Fathy Aboelmahasen F Dr. Mahmoud F. Aboelmahasen, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSc Student in Orthodontics

Study Record Dates

First Submitted

November 15, 2025

First Posted

March 6, 2026

Study Start

August 1, 2025

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 1, 2027

Last Updated

March 6, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations